Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies
Siow-Chin Heng, Sharon C-A Chen, C Orla Morrissey, Karin Thursky, Renee L Manser, Harini D De Silva, Catriona L Halliday, John F Seymour, Roger L Nation, David CM Kong, Monica A Slavin
Diagnostic Microbiology and Infectious Disease | ELSEVIER SCIENCE INC | Published : 2014
MS and SCAC have sat on advisory boards for and received research funding (not related to the current work) from Pfizer, MSD, and Gilead Sciences. COM has been a member of advisory boards for, received investigator-initiated grants from (not related to the current work), and given lectures for Gilead Sciences, Pfizer, MSD, and Orphan Australia. DCMK has sat on an advisory board for Pfizer and receives financial support (not related to the current work) from Pfizer, Roche, MSD, Novartis, and Gilead Sciences. All other authors: no conflict of interest. Preliminary data from this work were presented at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Denver, CO, USA, 2013, abstract M-1273.